This podcast highlights the impact of respiratory syncytial virus (RSV) on older adults. Experts discuss RSV's pathophysiology, risk factors, potential complications, and the vital role of new vaccines in protecting the aging population.
Supported by an independent medical educational grant from GSK
SPEAKERS
Kelly Pennington, MD
Ryan C. Maves, MD, FCCP